{"id":"W4394564034","doi":"10.1016/s2352-3026(24)00067-x","title":"Methodological challenges in the development of endpoints for myelofibrosis clinical trials","year":2024,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Myeloproliferative neoplasm; Clinical trial; Myeloid; Oncology; Clinical endpoint; Janus kinase 2; Surrogate endpoint; Internal medicine; Myeloid leukemia; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01633369,0.0001518566,0.001902679,0.0000631004,0.00005064748,0.00001097388,0.0001930801,0.000158062,0.00006762013],"category_scores_gemma":[0.003661953,0.00006113868,0.0002475646,0.0001076199,0.0001508528,0.00001698934,0.00004839061,0.0002370219,0.00002711667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002502298,"about_ca_system_score_gemma":0.000141481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001869601,"about_ca_topic_score_gemma":0.00005600456,"domain_scores_codex":[0.995545,0.002671086,0.001048646,0.000309975,0.0001564083,0.0002689009],"domain_scores_gemma":[0.9772255,0.02220941,0.0001454861,0.0003390603,0.00004336479,0.00003712154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004248204,0.001761493,0.04126265,0.003117128,0.001980195,0.0004492073,0.02338117,0.000003201886,0.0006285692,0.4248852,0.01595691,0.4823261],"study_design_scores_gemma":[0.01931446,0.00478648,0.4936278,0.002700109,0.002300492,0.002868936,0.00723947,0.0006926561,0.04552005,0.101383,0.3187604,0.0008062171],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.85458,0.01801555,0.002493862,0.1185842,0.0006745292,0.002747004,0.00003071339,0.00007260161,0.002801602],"genre_scores_gemma":[0.9659759,0.00339737,0.02821247,0.0009578799,0.0003897919,0.0009931412,0.00001700839,0.00001485857,0.00004162912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4815199,"threshold_uncertainty_score":0.5660962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.8278153183857964,"score_gpt":0.584567789265612,"score_spread":0.2432475291201843,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}